John Vissing

John Vissing

Clinical Professor

Member of:

  • Neurology


Publication year:
All
11 - 20 out of 24Page size: 10
  1. 2014
  2. Published

    A pilot study of muscle plasma protein changes after exercise

    Dahlqvist, J. R., Voss, L. G., Lauridsen, T., Krag, T. O. & Vissing, John, Feb 2014, In: Muscle & Nerve. 49, 2, p. 261-266 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Bezafibrate in skeletal muscle fatty acid oxidation disorders: A randomized clinical trial

    Ørngreen, M. C., Madsen, K. L., Preisler, N., Andersen, G., Vissing, John & Laforêt, P., 18 Feb 2014, In: Neurology. 82, 7, p. 607-613 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy

    Mosbech, M., Olsen, A. S. B., Neess, D., Ben-David, O., Klitten, L. L., Larsen, J., Sabers, A., Vissing, John, Nielsen, Jørgen Erik, Hasholt, Lis Frydenreich, Klein, A. D., Tsoory, M. M., Hjalgrim, H., Tommerup, Niels, Futerman, A. H., Møller, R. S. & Færgeman, N. J., 28 Feb 2014, In: Annals of Clinical and Translational Neurology. 1, 2, p. 88-98 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Pharmacologic Treatment of Downstream of Tyrosine Kinase 7 Congenital Myasthenic Syndrome

    Witting, N. & Vissing, John, Mar 2014, In: Archives of Neurology. 71, 3, p. 350-354 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy

    Citirak, G., Witting, N., Duno, M., Werlauff, U., Petri, H. & Vissing, John, Apr 2014, In: Neuromuscular Disorders. 24, 4, p. 325-30 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale

    Werlauff, U., Højberg, A., Firla-Holme, R., Steffensen, B. F. & Vissing, John, Jun 2014, In: Quality of Life Research. 23, 5, p. 1479-1488 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Muscle strength in myasthenia gravis

    Cejvanovic, S. & Vissing, John, Jun 2014, In: Acta Neurologica Scandinavica. 129, 6, p. 367-373 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: A cross-sectional study

    Petri, H., Witting, N., Ersbøll, M. K., Sajadieh, Ahmad, Dunø, M., Helweg-Larsen, S., Vissing, John, Køber, Lars Valeur & Bundgaard, H., 1 Jun 2014, In: International Journal of Cardiology. 174, 1, p. 31-36 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Aerobic training in patients with anoctamin 5 myopathy and hyperckemia

    Vissing, C. R., Preisler, N., Husu, E., Prahm, K. P. & Vissing, John, Jul 2014, In: Muscle & Nerve. 50, 1, p. 119-123 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Cardiac involvement in myotonic dystrophy: a nationwide cohort study

    Lund, M., Diaz, L. J., Ranthe, M. F., Petri, H., Duno, M., Juncker, I., Eiberg, Hans Rudolf Lytchoff, Vissing, John, Bundgaard, H., Wohlfahrt, J. & Melbye, M., 21 Aug 2014, In: European Heart Journal. 35, 32, p. 2158-2164 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 915367